174 related articles for article (PubMed ID: 1327273)
1. [The proton MR spectroscopy of intracranial tumors. The differential diagnostic aspects for gliomas, metastases and meningiomas].
Vogl TJ; Jassoy A; Söllner O; Becker C; Hamburger C; Dadashi A; Sauter R; Lissner J
Rofo; 1992 Oct; 157(4):371-7. PubMed ID: 1327273
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
4. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas.
Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A
Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335
[TBL] [Abstract][Full Text] [Related]
5. Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience.
Kumar A; Kaushik S; Tripathi RP; Kaur P; Khushu S
Neurol India; 2003 Dec; 51(4):474-8. PubMed ID: 14742925
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
7. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].
Yu HW; Tanabe S; Yamaki T; Harada K; Hashi K
No Shinkei Geka; 2000 Dec; 28(12):1063-9. PubMed ID: 11193526
[TBL] [Abstract][Full Text] [Related]
9. [1H magnetic resonance spectroscopy in intracranial tumors and cerebral ischemia].
Felber SR
Radiologe; 1993 Nov; 33(11):626-32. PubMed ID: 8278589
[TBL] [Abstract][Full Text] [Related]
10. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.
Ng WH; Lim T
J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298
[TBL] [Abstract][Full Text] [Related]
11. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
[TBL] [Abstract][Full Text] [Related]
12. [Nuclear spin tomography in brain tumors. Evaluation of 40 confirmed cases].
Uhlenbrock D; Beyer HK; Grote W
Rofo; 1985 Nov; 143(5):501-7. PubMed ID: 2999887
[TBL] [Abstract][Full Text] [Related]
13. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
14. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases.
Fan G; Sun B; Wu Z; Guo Q; Guo Y
Clin Radiol; 2004 Jan; 59(1):77-85. PubMed ID: 14697379
[TBL] [Abstract][Full Text] [Related]
15. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
[TBL] [Abstract][Full Text] [Related]
16. [Magnetic resonance proton spectroscopy in neurooncology--preliminary report].
Kubas B; Tarasów E; Dzienis W; Łebkowski W; Zimnoch L; Dziecioł J; Siergiejczyk L; Walecki J; Lewko J
Neurol Neurochir Pol; 2001; 35 Suppl 5():90-100. PubMed ID: 11935688
[TBL] [Abstract][Full Text] [Related]
17. [Magnetic resonance tomography of intracranial tumors: use of contrast media versus T2-weighted tomograms].
Schörner W; Laniado M; Claussen C; Kazner E; Niendorf HP; Felix R
Rofo; 1986 Mar; 144(3):315-22. PubMed ID: 3008234
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
19. Antidesmosomal monoclonal antibody in the diagnosis of intracranial tumours.
Parrish EP; Steart PV; Garrod DR; Weller RO
J Pathol; 1987 Nov; 153(3):265-73. PubMed ID: 3323433
[TBL] [Abstract][Full Text] [Related]
20. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
